Biologically relevant orthotopic neuroblastoma xenograft models: primary adrenal tumor growth and spontaneous distant metastasis.
Elias Drakos , Carol J. Thiele , Chand Khanna , Maria Tsokos
in Vivo 16 ( 2) 77 -85
106
2002
Survivin is a Therapeutic Target in Ewing Sarcoma
Nikolina Dioufa , Maria Tsokos
The FASEB Journal 29
2015
Intracellular activation of complement 3 mediates intestinal tissue damage during mesenteric ischemia (INC1P.356)
George Tsokos , Jurandir Dalle Lucca , Lakshmi Kannan , Maria Tsokos
Journal of Immunology 194
2015
Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity.
Nicholas Mitsiades , Vassiliki Poulaki , Maria Tsokos , Wei-hsuan Yu
Cancer Research 61 ( 2) 577 -581
523
2001
Pluripotent Tumor Cells in Benign Pituitary Adenomas Associated with Multiple Endocrine Neoplasia Type 1
Alexander O. Vortmeyer , Irina A. Lubensky , Svetlana Pack , Edward H. Oldfield
Cancer Research 58 ( 20) 4715 -4720
8
1998
Ewing's sarcoma family tumors are sensitive to tumor necrosis factor-related apoptosis-inducing ligand and express death receptor 4 and death receptor 5.
Constantine Mitsiades , Nicholas Mitsiades , Vassiliki Poulaki , Maria Tsokos
Cancer Research 61 ( 6) 2704 -2712
125
2001
Stimulation of Tumor Growth by Recombinant Human Insulin-like Growth Factor-I (IGF-I) Is Dependent on the Dose and the Level of IGF-I Receptor Expression
Andrew A Butler , Vicky A Blakesley , Maria Tsokos , Vasiliki Pouliki
Cancer Research 58 ( 14) 3021 -3027
68
1998
Role of IL-17 in intestinal ischemia-reperfusion injury. (MUC2P.829)
George Tsokos , Maria Tsokos , Robin Bosse , Mayya Geha
Journal of Immunology 192
2014
Induction of Caspase 8 by Interferon γ Renders Some Neuroblastoma (NB) Cells Sensitive to Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL) but Reveals That a Lack of Membrane TR1/TR2 Also Contributes to TRAIL Resistance in NB
Carol J. Thiele , Leonard H. Wexler , Udo Kontny , Melinda S. Merchant
Cancer Research 63 ( 5) 1122 -1129
93
2003
Phosphoprotein pathway mapping: AKT/mTOR activation is negatively associated with childhood Rhabdomyosarcoma survival
William Meyer , Maria Tsokos , Gabriel S. Eichler , Seth M. Steinberg
Clinical Cancer Research 12
2006
Differential Distribution of the Neuron-Associated Class III β-Tubulin in Neuroendocrine Lung Tumors
Christos D. Katsetos , Harry S. Cooper , George Kontogeorgos , Yunxia Yu
Archives of Pathology & Laboratory Medicine 124 ( 4) 535 -544
50
2000
The TRAIL to arthritis
George C. Tsokos , Maria Tsokos
Journal of Clinical Investigation 112 ( 9) 1315 -1317
22
2003
In Vivo Treatment with Antibody against IGF-1 Receptor Suppresses Growth of Human Rhabdomyosarcoma and Down-Regulates p34cdc2
Thea Kalebic , Maria Tsokos , Lee J. Helman
Cancer Research 54 ( 21) 5531 -5534
184
1994
Phenylbutyrate Induces Cell Differentiation and Modulates Epstein-Barr Virus Gene Expression in Burkitt’s Lymphoma Cells
Alain Thibault , Maria Tsokos , Dvorit Samid , Matia Bar-Ner
Clinical Cancer Research 5 ( 6) 1509 -1516
18
1999
Biology of childhood osteogenic sarcoma and potential targets for therapeutic development : Meeting summary
Irene Andrulis , Eugenie S Kleinerman , Jeffrey Toretsky , Marc Ladanyi
Clinical Cancer Research 9 ( 15) 5442 -5453
151
2003
Frequency and Diversity of p53 Mutations in Childhood Rhabdomyosarcoma
Tetsuya Mitsudomi , Naomi J. Winick , Marion M. Nau , Cynthia Chavez Kappel
Cancer Research 52 ( 8) 2243 -2247
235
1992
Fas-mediated Apoptosis in Neuroblastoma Requires Mitochondrial Activation and Is Inhibited by FLICE Inhibitor Protein and bcl-2
Nicholas Mitsiades , Vassiliki Poulaki , Maria Tsokos , Maria E. Romero
Cancer Research 61 ( 12) 4864 -4872
75
2001
Expression of transforming growth factor-beta isoforms in small round cell tumors of childhood. An immunohistochemical study.
Maria Tsokos , Michael B. Sporn , Roma S. Chandra , Sudesh Kapur
American Journal of Pathology 142 ( 1) 49 -58
30
1993
Histopathologic changes associated with fialuridine hepatotoxicity.
Jay H. Hoofnagle , Michael J. Gaffey , Stephen E. Straus , David E. Kleiner
Modern Pathology 10 ( 3) 192 -199
50
1997
Targeting of EWS/FLi-1 by siRNA inhibits survivin expression and sensitizes ESFT cells to TRAIL
Maria Tsokos , Guang Li
Cancer Research 67 522 -522
2007